Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia

This study has been completed.
Sponsor:
Collaborators:
The Danish Child Cancer Foundation
TauroPharm
Information provided by (Responsible Party):
Mette Møller Handrup, Aarhus University Hospital
ClinicalTrials.gov Identifier:
NCT00735813
First received: August 14, 2008
Last updated: September 4, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)